65 related articles for article (PubMed ID: 21749573)
1. Death-associated protein kinase 1 variation and Parkinson's disease.
Dachsel JC; Wider C; Vilariño-Güell C; Aasly JO; Rajput A; Rajput AH; Lynch T; Craig D; Krygowska-Wajs A; Jasinska-Myga B; Opala G; Barcikowska M; Czyzewski K; Wu RM; Heckman MG; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
Eur J Neurol; 2011 Aug; 18(8):1090-3. PubMed ID: 21749573
[TBL] [Abstract][Full Text] [Related]
2. Association of DAPK1 genetic variations with Alzheimer's disease in Han Chinese.
Wu ZC; Zhang W; Yu JT; Zhang Q; Tian Y; Lu RC; Yu NN; Chi ZF; Tan L
Brain Res; 2011 Feb; 1374():129-33. PubMed ID: 21167819
[TBL] [Abstract][Full Text] [Related]
3. DAPK1 is associated with FTD and not with Alzheimer's disease.
Tedde A; Piaceri I; Bagnoli S; Lucenteforte E; Piacentini S; Sorbi S; Nacmias B
J Alzheimers Dis; 2012; 32(1):13-7. PubMed ID: 22785394
[TBL] [Abstract][Full Text] [Related]
4. DAPK1 variants are associated with Alzheimer's disease and allele-specific expression.
Li Y; Grupe A; Rowland C; Nowotny P; Kauwe JS; Smemo S; Hinrichs A; Tacey K; Toombs TA; Kwok S; Catanese J; White TJ; Maxwell TJ; Hollingworth P; Abraham R; Rubinsztein DC; Brayne C; Wavrant-De Vrièze F; Hardy J; O'Donovan M; Lovestone S; Morris JC; Thal LJ; Owen M; Williams J; Goate A
Hum Mol Genet; 2006 Sep; 15(17):2560-8. PubMed ID: 16847012
[TBL] [Abstract][Full Text] [Related]
5. Rs4878104 contributes to Alzheimer's disease risk and regulates DAPK1 gene expression.
Hu Y; Cheng L; Zhang Y; Bai W; Zhou W; Wang T; Han Z; Zong J; Jin S; Zhang J; Jiang Q; Liu G
Neurol Sci; 2017 Jul; 38(7):1255-1262. PubMed ID: 28429084
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
[TBL] [Abstract][Full Text] [Related]
7. Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease.
Guo Y; Le WD; Jankovic J; Yang HR; Xu HB; Xie WJ; Song Z; Deng H
Mov Disord; 2011 Aug; 26(9):1729-32. PubMed ID: 21469209
[TBL] [Abstract][Full Text] [Related]
8. Variants in the LRRK1 gene and susceptibility to Parkinson's disease in Norway.
Haugarvoll K; Toft M; Ross OA; White LR; Aasly JO; Farrer MJ
Neurosci Lett; 2007 Apr; 416(3):299-301. PubMed ID: 17324517
[TBL] [Abstract][Full Text] [Related]
9. Association study of SCARB2 rs6812193 polymorphism with Parkinson's disease in Han Chinese.
Chen S; Zhang Y; Chen W; Wang Y; Liu J; Rong TY; Ma JF; Wang G; Zhang J; Pan J; Xiao Q; Chen SD
Neurosci Lett; 2012 May; 516(1):21-3. PubMed ID: 22465138
[TBL] [Abstract][Full Text] [Related]
10. Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.
von Otter M; Bergström P; Quattrone A; De Marco EV; Annesi G; Söderkvist P; Wettinger SB; Drozdzik M; Bialecka M; Nissbrandt H; Klein C; Nilsson M; Hammarsten O; Nilsson S; Zetterberg H
BMC Med Genet; 2014 Dec; 15():131. PubMed ID: 25496089
[TBL] [Abstract][Full Text] [Related]
11. Genetic studies of the protein kinase AKT1 in Parkinson's disease.
Ran C; Westerlund M; Anvret A; Willows T; Sydow O; Galter D; Belin AC
Neurosci Lett; 2011 Aug; 501(1):41-4. PubMed ID: 21741444
[TBL] [Abstract][Full Text] [Related]
12. The role of SCARB2 as susceptibility factor in Parkinson's disease.
Hopfner F; Schulte EC; Mollenhauer B; Bereznai B; Knauf F; Lichtner P; Zimprich A; Haubenberger D; Pirker W; Brücke T; Peters A; Gieger C; Kuhlenbäumer G; Trenkwalder C; Winkelmann J
Mov Disord; 2013 Apr; 28(4):538-40. PubMed ID: 23408458
[TBL] [Abstract][Full Text] [Related]
13. Association of P2X7 receptor gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population.
Liu H; Han X; Li Y; Zou H; Xie A
Neurosci Lett; 2013 Jun; 546():42-5. PubMed ID: 23648388
[TBL] [Abstract][Full Text] [Related]
14. LINGO-2 polymorphism and the risk of Parkinson's disease in Taiwan.
Su FC; Chen CM; Chen YC; Wu YR
Parkinsonism Relat Disord; 2012 Jun; 18(5):609-11. PubMed ID: 22123311
[TBL] [Abstract][Full Text] [Related]
15. No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer's disease.
Minster RL; DeKosky ST; Kamboh MI
Neurobiol Aging; 2009 Nov; 30(11):1890-1. PubMed ID: 18336955
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of caffeine intake in subjects with genetic susceptibility to Parkinson's Disease.
Kumar PM; Paing SS; Li H; Pavanni R; Yuen Y; Zhao Y; Tan EK
Sci Rep; 2015 Nov; 5():15492. PubMed ID: 26522888
[TBL] [Abstract][Full Text] [Related]
17. ATXN8 -62 G/A promoter polymorphism and risk of Taiwanese Parkinson's disease.
Chen IC; Wu YR; Yang SJ; Kao SH; Chen YC; Chang KH; Lee CM; Lee-Chen GJ; Chen CM
Eur J Neurol; 2012 Nov; 19(11):1462-9. PubMed ID: 22577844
[TBL] [Abstract][Full Text] [Related]
18. LINGO1 gene analysis in Parkinson's disease phenotypes.
Lorenzo-Betancor O; Samaranch L; García-Martín E; Cervantes S; Agúndez JA; Jiménez-Jiménez FJ; Alonso-Navarro H; Luengo A; Coria F; Lorenzo E; Irigoyen J; Pastor P;
Mov Disord; 2011 Mar; 26(4):722-7. PubMed ID: 21506150
[TBL] [Abstract][Full Text] [Related]
19. Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson's disease.
Lee JY; Jeon BS; Kim HJ; Park SS
Parkinsonism Relat Disord; 2012 Jan; 18(1):76-8. PubMed ID: 21900033
[TBL] [Abstract][Full Text] [Related]
20. RIC3 variants are not associated with Parkinson's disease in French-Canadians and French.
Ross JP; Dupré N; Dauvilliers Y; Strong S; Dionne-Laporte A; Dion PA; Rouleau GA; Gan-Or Z
Neurobiol Aging; 2017 May; 53():194.e9-194.e11. PubMed ID: 28153381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
